To ring in the new year, we have a few exciting updates about Pain Connection, our network of support groups.

Pain Connection Live is moving to Zoom!

Since it was launched in 2011, Pain Connection Live has provided support to more than a thousand individuals over the phone. This year, however, we’ve realized the value of videoconferencing. It’s wonderful to be able to not only hear but see one another, even from the comfort of home.

Read More

By: Malcolm Herman

One day I’ll write the definitive best-selling book about caregiving (yes, another one!) full of helpful tips, like take care of yourself, accept offers of help, eat your veggies, and so forth. But after thinking about the subject one way or another for 25 years, I have come to realize that there is no simple definition of “caregiver.” Or to put it another way, there are so many people of all ages fulfilling some kind of caregiving role in our society—for parents, children, siblings, spouses, partners, and so forth—that the term really has no single meaning.

Read More

In honor of Veterans Day, the U.S. Pain Foundation is pleased to announce a new virtual support group for veterans and active members of the military dealing with chronic pain. The support group is part of Pain Connection, the organization’s national network of support groups.

“Veterans are 40 percent more likely to experience chronic pain than civilians,” says Gwenn Herman, LCSW, DCSW, Pain Connection’s Clinical Director. “In addition, they face high rates of post-traumatic stress disorder. Veterans and active military members need and deserve specialized support that recognizes the unique challenges they face.”

Read More
Sue Ann Stelfox, right, with Nicole Hemmenway at the 2019 Advocacy Summit.

In honor of beloved ambassador and support group leader, Sue Ann Stelfox, who passed away on June 30 after a long battle with cancer, U.S. Pain Foundation is establishing the Sue Ann Stelfox Pain Connection Training Scholarship. The scholarship will cover up to $500 in travel costs associated with attending U.S. Pain’s Pain Connection training weekends for chronic pain support group leaders.

“Sue Ann was an incredible advocate for people with pain and, quite simply, a wonderful person,” says Nicole Hemmenway, U.S. Pain CEO. “We were heartbroken at the news of her illness and passing. I can think of no better way to honor her passion for helping others than through this scholarship, which gives people with pain the training and tools they need to establish support groups in their area.”

Read More

Several of U.S. Pain’s in-person support groups, part of the Pain Connection program, are beginning to transition to Zoom. All U.S. Pain in-person meetings and events were put on hold due to COVID-19.

Pain Connection typically offers roughly 20 in-person support groups across the country. So far, six groups have made the transition to meeting virtually using the Zoom platform. While the groups are available remotely, to preserve the intimate feel, they are geared toward individuals in that state or geographic area.

Read More

Pain Connection continues its interactive series, “Building Your Toolbox,” this Tuesday, July 7 at 7:30 pm ET. The meeting will focus on acupressure with Lisa Marie Price. In private practice in Chinese Medicine for 25 years, Lisa Marie Price is a national board-certified acupuncturist (NCCAOM) and received her master’s degree in Acupuncture at the Traditional Acupuncture Institute. For eight years, Price served as faculty and Dean of Students at the Tai Sophia Institute for the Healing Arts, but now devotes herself full-time to her patients. As a founding member of U.S. Pain’s National Coalition for Chronic Pain Providers and Professionals, Price advocates both locally and nationally for improved services and treatment options for chronic pain patients.

Read More

To provide more support and tips for self-management during the pandemic, Pain Connection has launched an interactive series, “Building Your Toolbox,” held the first Tuesday of the month. Each meeting in the series focuses on discussing a different pain modality with an expert. With the current health crisis, fear and stress seem to be at an all-time high, especially for pain warriors. We would like to encourage our pain warriors to create a toolbox of treatment modalities that can help you thrive all the time, not just during the pandemic.

Read More

Mindfull

By: Mia Maysack

How are we able to go about pursuing or even simply believing in the concept of wellness, while attempting to cope with the opposite of being well?

At a physical therapy appointment a few years back, I met with a provider who used to experience debilitating pain himself after an accident. He’d since become pain-free and had a certain arrogance, as if he’d cracked the code, so I looked forward to working together.

Read More

In our recent survey, when asked “What resources would be most helpful to you right now,” a majority of you responded that you need help handling the added stress and anxiety of COVID-19.

With that in mind, we’d like to share details about an upcoming Zoom webinar: “Finding balance during crisis: Tools from a pain psychologist” on Monday, May 4, at 7 pm ET, with pain psychologist Shamin Ladhani, PsyD.

Read More

Buy Bactrim

Antimicrobial Therapy of Vibrio cholerae
Vibrio cholerae (coughing or severe pain) are bacteria that produce an unpleasant and stinging liquid known as cough syrup. This liquid may be a green-fever or bitter-sweet substance. It is used during the first 24 to 48 hours after a cough has occurred. It is commonly used as treatment for other viral illnesses (such as the common cold and influenza).
Antibiotics may be given to protect other people from other viral illnesses such as common colds caused by the common cold bacterium B, but not against the respiratory bacterium Mycobacterium tuberculosis, which is usually killed by the administration of ciprofloxacin. Once treatment is complete the symptoms will likely disappear completely as these bacterial infections eventually dissipate within four to six weeks or perhaps several weeks after the disease has ceased (see Table 1 for information about the duration of these infections) (Walsh et. Al., 2001). In patients with an existing, or suspected, severe chronic disease, therapy with antibiotics should be commenced promptly so that both the patient and her physician can monitor the results of the therapy.
Antibiotic Therapy of Cryptosporidium venetis
Cryptosporidium venetis (pulmonary congestion) is a contagious disease caused by A standard treatment regimen consists of four to eight antibiotics given weekly or if necessary if symptoms persist. There are usually several different types of antibiotic, which vary depending on the severity and frequency of the infection and how it is treated. A multidisciplinary team (e.g. dermatologists, infectious disease specialists, microbiology experts) usually assess and advise and, in some instances, advise on alternative drug therapy (antibiotics) for the particular infection.
There are also several classes of antifungal medications, usually given in combination with anti-bacterial agents, such as clindamycin, tetracycline, or a combination of the two. These include the various class I–II, class II, and IV medications, including phenytoin, chloramphenicol, ketoconazole, thioglycol, quinidine sulfites (papaverine sulfites), fluralin [sulfonamides], praziquantel, rifampin [tetracycline and phenytoin], sequinoxamine, carbapenems and carboplatin, and carboplatin-resistant carbapenemase inhibitors (CB-ARSI) including amikacin (Cepheus) and fosamprenavir (Pseudogapens and its analogues), elitemedshop.com. (There are several classes of antibiotics including the various class I–II, class II, and IV medications, including phenytoin, chloramphenicol, ketoconazole, thioglycol, quinidine sulfites (papaverine sulfites), fluralin [sulfonamides], praziquantel/tetracycline and phenytoin, and carboplatin and its derivatives. However, since the introduction of antibiotics in 1945, most of these class I–II and III–IV antibiotics are now being developed in combination with other antibiotics and these classes have been increasingly incorporated into the current multidisciplinary approach.)

Read More